Syntal Capital Partners’s NuVasive, Inc. NUVA Stock Holding History

Syntal Capital Partners’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-6,870	Closed	-$263K	–	235
2014 Q2	$263K	Hold	6,870	–	–	0.13%	57
2014 Q1	$263	Buy	+6,870	New	+$252K	0.15%	52

Other funds holding NUVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Syntal Capital Partners's NUVA Position: Q3 2014 in Review

Syntal Capital Partners sold out of NuVasive, Inc. (NUVA) in Q3 2014, closing a stake of 6,870 shares — an estimated $263K sold.

Syntal Capital Partners first reported a position in NUVA in Q1 2014 and held it in 2 quarters. The position peaked at $263K in Q2 2014. 182 funds tracked by Wall St. Rank hold NUVA as of Q3 2014.

Syntal Capital Partners reported no remaining NuVasive, Inc. position as of Q3 2014 after selling out during the quarter.
Syntal Capital Partners sold 6,870 NuVasive, Inc. shares in Q3 2014, an estimated $263K.
Syntal Capital Partners first reported a position in NuVasive, Inc. in Q1 2014 and held it in 2 quarters.
Syntal Capital Partners's NuVasive, Inc. position peaked at $263K in Q2 2014.
182 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2014.

Based on Syntal Capital Partners's 13F filing for Q3 2014, filed 12 Nov 2014.